What was the prescribed dosage?
advertisement

Here is the some steps to help you to save money on Vinorelbin-HAEMATO purchase.


Read drug prescription


What is Vinorelbin-HAEMATO

Vinorelbin-HAEMATO is cancer medication that interferes with the growth of cancer cells and slows their spread in the body.
Vinorelbin-HAEMATO is used to treat non-small cell lung cancer.
Vinorelbin-HAEMATO is sometimes used in combination with other cancer medications.
Vinorelbin-HAEMATO may also be used for other purposes not listed in Vinorelbin-HAEMATO guide.

How is Vinorelbin-HAEMATO given?

Vinorelbin-HAEMATO is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion.
Vinorelbin-HAEMATO is usually given once every 7 days. You may also receive the medication once every 6 weeks. Follow your doctor's instructions.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
Vinorelbin-HAEMATO can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your cancer treatments may be delayed based on the results of these tests. Do not miss any scheduled visits to your doctor.

Vinorelbin-HAEMATO side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

Less serious side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
advertisement

Vinorelbin-HAEMATO dosing

Usual Adult Dose for Non-Small Cell Lung Cancer:

Vinorelbin-HAEMATO 30 mg/m2 administered weekly as a single agent. The recommended method of administration is an intravenous injection over 6 to 10 minutes. In controlled trials, single-agent Vinorelbin-HAEMATO was given weekly until progression or dose-limiting toxicity.
or
Vinorelbin-HAEMATO 25 mg/m2 weekly in combination with cisplatin. Blood counts should be checked weekly to determine whether dose reductions of Vinorelbin-HAEMATO and/or cisplatin are necessary.
or
Vinorelbin-HAEMATO 30 mg/m2 weekly in combination with cisplatin.

Select the most affordable brand or generic drug


StrengthQuantityPrice, USDCountry
5 mg10 Tablet$0.47
AVISERA Capsule/ Tablet / 5mg (10 units) $0.42Avalanche Pharmaceuticals
AVISERA tab 5 mg x 10's $0.47Avalanche
5 mg x 100's $4.70
Avisera 5mg TAB / 100 $4.70
AVISERA Capsule/ Tablet / 15mg (10 units) $0.63Avalanche Pharmaceuticals
10 mg/1Vial Injection$37.80
NEOBEN inj 10 mg x 1 mL x 5ml $159.94Neon Labs
Neoben 10mg Injection $16.26Neon Laboratories Ltd
NEOBEN 10MG INJECTION 1 vial(s) (1 ML injection each) $16.26Neon Laboratories Ltd
Neoben 10 mg Injection $0.03
NEOBEN inj 10 mg x 1 mL x 1ml $41.58Neon Labs
50 mg/1Vial Injection$149.58
50 mg x 1's $149.58
RELBOVIN inj 50 mg x 5ml $149.58Miracalus
Relbovin 50mg VIAL / 1 $149.58
10 mg x 1's $36.05
RELBOVIN inj 10 mg x 1ml $36.05Miracalus
Relbovin 10mg VIAL / 1 $36.05
Vinelbine 50 mg Injection $0.15
10 mg x 1 mL x 5ml $163.14
VINELBINE Injection / 10mg (1ml units) $36.64Dabur Pharmaceuticals
50 mg/1Vial Injection$163.14
Vinelbine 20mg x 5mL VIAL / 1 $155.75
Vinelbine 10mg x 1mL VIAL / 5ml $163.14
VINELBINE inj 10 mg x 1 mL x 1ml $38.37Fresenius Kabi
Vinorelbine 50 mg/5 ml vial $27.60
Navelbine 50 mg/5 ml vial $42.00
50 mg/1Vial Injection$171.29
Vinorelmil 50 mg Injection $0.17
Vinorelmil 10 mg Injection $0.03
advertisement

References

  1. "Vinorelbine". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  2. "Vinorelbine". http://www.drugbank.ca/drugs/DB0036... (accessed August 28, 2018).
  3. "Vinorelbine: link to the compound information in wikipedia.". https://en.wikipedia.org/wiki/Vinor... (accessed August 28, 2018).

Vinorelbin-HAEMATO - Frequently asked Questions

Can Vinorelbin-HAEMATO be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Who should not take Vinorelbin-HAEMATO?

You should not use this medication if you are allergic to it, or if you have severely low white blood cell counts.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:

FDA pregnancy category D. Vinorelbin-HAEMATO can cause harm to an unborn baby or cause birth defects. Before you receive Vinorelbin-HAEMATO, tell your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.

It is not known whether Vinorelbin-HAEMATO passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are being treated with Vinorelbin-HAEMATO.

How should I take Vinorelbin-HAEMATO?

You should not use this medication if you are allergic to it, or if you have severely low white blood cell counts.

Do not use Vinorelbin-HAEMATO if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.

Before you receive Vinorelbin-HAEMATO, tell your doctor if you have liver disease, bone marrow suppression, a nerve disorder, or if you have received radiation therapy or other cancer treatments.

Vinorelbin-HAEMATO is sometimes used in combination with other cancer medications.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Vinorelbin-HAEMATO is injected.

Vinorelbin-HAEMATO can lower blood cells that help your body fight infections. Avoid being near people who have colds, the flu, or other contagious illnesses. Your blood will need to be tested on a regular basis. Do not miss any scheduled appointments. Contact your doctor at once if you develop signs of infection.

Do not receive a "live" vaccine while you are being treated with Vinorelbin-HAEMATO, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you.

What other drugs will affect Vinorelbin-HAEMATO?

Tell your doctor about all other medications you use, especially:

This list is not complete and there may be other drugs that can interact with Vinorelbin-HAEMATO. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Can Vinorelbin-HAEMATO be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Vinorelbin-HAEMATO be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

advertisement

Reviews

Following the study conducted by gmedication.com on Vinorelbin-HAEMATO, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Vinorelbin-HAEMATO. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reported useful

No survey data has been collected yet


Patient reported side effects

No survey data has been collected yet


Patient reported price estimates

No survey data has been collected yet


Patient reported frequency of use

No survey data has been collected yet


Patient reported doses

No survey data has been collected yet


Patient reported time for results

No survey data has been collected yet


Patient reported administration

No survey data has been collected yet


Patient reported age

No survey data has been collected yet


Patient reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 27 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology